Have a personal or library account? Click to login
CRISPR/Cas Systems as Diagnostic and Potential Therapeutic Tools for Enterohemorrhagic Escherichia coli Cover

CRISPR/Cas Systems as Diagnostic and Potential Therapeutic Tools for Enterohemorrhagic Escherichia coli

Archivum Immunologiae et Therapiae Experimentalis
Volume 73 (2025): Issue 1 (January 2025)
By: Agnieszka Bogut,  Anna Kołodziejek,  Scott A. Minnich and  Carolyn J. Hovde  
Open Access
|Jan 2025

Authors

Agnieszka Bogut

agnieszka.bogut@umlub.pl

Chair and Department of Medical Microbiology, Medical University of Lublin, Lublin, Poland

Anna Kołodziejek

Department of Animal, Veterinary, and Food Science, University of Idaho, Moscow, USA

Scott A. Minnich

Department of Animal, Veterinary, and Food Science, University of Idaho, Moscow, USA

Carolyn J. Hovde

Department of Animal, Veterinary, and Food Science, University of Idaho, Moscow, USA
DOI: https://doi.org/10.2478/aite-2025-0003 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: Jun 17, 2024
|
Accepted on: Nov 4, 2024
|
Published on: Jan 7, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
EHEC,
CRISPR/Cas,
Cas9,
Cas12,
Probiotics,
O157:H7
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2025 Agnieszka Bogut, Anna Kołodziejek, Scott A. Minnich, Carolyn J. Hovde, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2025): Issue 1 (January 2025)Next article